PILOPINE Drug Patent Profile
✉ Email this page to a colleague
When do Pilopine patents expire, and when can generic versions of Pilopine launch?
Pilopine is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PILOPINE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pilopine
A generic version of PILOPINE was approved as pilocarpine hydrochloride by INNOGENIX on December 22nd, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PILOPINE?
- What are the global sales for PILOPINE?
- What is Average Wholesale Price for PILOPINE?
Summary for PILOPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PILOPINE at DailyMed |
US Patents and Regulatory Information for PILOPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | PILOPINE HS | pilocarpine hydrochloride | GEL;OPHTHALMIC | 018796-001 | Oct 1, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
